About Response Genetics (OTCMKTS:RGDXQ)
Response Genetics, Inc., a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples. It provides testing services for non-small cell lung cancer, colorectal cancer, gastric and gastroesophageal cancer, melanoma and thyroid cancer, breast cancer, and glioma through its ResponseDX: Lung, ResponseDX: Colon, ResponseDX: Gastric, ResponseDX: Melanoma, ResponseDX: Thyroid, ResponseDX: Breast, ResponseDX: Glioma, and ResponseDX: Tissue of Origin test suites. The company also develops tests for other tumor types; and provides technical component and professional component testing services. It serves community based oncologists, pathologists, physician offices, hospitals, and pharmaceutical companies through its sales force. The company was formerly known as Bio Type, Inc. and changed its name to Response Genetics, Inc. in August 2000. Response Genetics, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
Industry, Sector and Symbol
Industry Diagnostic substances
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Response Genetics (OTCMKTS:RGDXQ) Frequently Asked Questions
What is Response Genetics' stock symbol?
Response Genetics trades on the OTCMKTS under the ticker symbol "RGDXQ."
How were Response Genetics' earnings last quarter?
Response Genetics, Inc. (OTCMKTS:RGDXQ) issued its earnings results on Tuesday, March, 31st. The medical research company reported ($0.09) EPS for the quarter. The medical research company had revenue of $4.10 million for the quarter. View Response Genetics' Earnings History.
Who are some of Response Genetics' key competitors?
Some companies that are related to Response Genetics include Idexx Laboratories (IDXX), Ipsen (IPSEY), Neogen (NEOG), Immunomedics (IMMU), Quidel (QDEL), Myriad Genetics (MYGN), Intellia Therapeutics (NTLA), New England Nuclear (LNTH), Meridian Bioscience (VIVO), Oxford Immunotec Global (OXFD), Nymox Pharmaceutical (NYMX), Quotient (QTNT), Trinity Biotech (TRIB), Celldex Therapeutics (CLDX) and AspenBio Pharma (RIOT).
Who are Response Genetics' key executives?
Response Genetics' management team includes the folowing people:
- Thomas A. Bologna, Chairman of the Board, Chief Executive Officer (Age 66)
- Kevin Roy Harris, Chief Financial Officer, Vice President (Age 47)
- Adanech Getachew, General Counsel (Age 37)
- Kirk K. Calhoun, Lead Independent Director (Age 73)
- Michael Serruya, Director (Age 51)
- Sam Chawla, Independent Director (Age 41)
- David R Schreiber, Independent Director (Age 55)
- Richard A. van den Broek, Independent Director (Age 49)
Has Response Genetics been receiving favorable news coverage?
News headlines about RGDXQ stock have been trending somewhat positive recently, Accern Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Response Genetics earned a daily sentiment score of 0.14 on Accern's scale. They also gave news coverage about the medical research company an impact score of 45.28 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next several days.
How do I buy shares of Response Genetics?
Shares of RGDXQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Response Genetics' stock price today?
One share of RGDXQ stock can currently be purchased for approximately $0.0004.
How big of a company is Response Genetics?
Response Genetics has a market capitalization of $20,000.00.
How can I contact Response Genetics?
Response Genetics' mailing address is 1640 MARENGO ST 7TH FLOOR, LOS ANGELES CA, 90033. The medical research company can be reached via phone at 323-224-3900 or via email at [email protected]
MarketBeat Community Rating for Response Genetics (RGDXQ)MarketBeat's community ratings are surveys of what our community members think about Response Genetics and other stocks. Vote "Outperform" if you believe RGDXQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RGDXQ will underperform the S&P 500 over the long term. You may vote once every thirty days.
Response Genetics (OTCMKTS:RGDXQ) Analyst Ratings History
(Data available from 4/24/2016 forward)
Response Genetics (OTCMKTS:RGDXQ) Earnings History and Estimates Chart
Response Genetics (OTCMKTS RGDXQ) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/14/2015||Q115||($0.10)||$3.90 million||$3.80 million||View||Listen|
|11/13/2014||Q3 2014||($0.09)||$4.47 million||View||N/A|
|8/14/2014||Q214||($0.08)||$3.90 million||$4.30 million||View||N/A|
|5/8/2014||Q114||($0.06)||($0.03)||$5.50 million||$3.90 million||View||N/A|
|3/20/2014||Q413||($0.07)||($0.09)||$5.30 million||$4.80 million||View||N/A|
|11/7/2013||Q313||($0.07)||($0.08)||$5.40 million||$4.10 million||View||N/A|
|8/8/2013||Q2 2013||($0.04)||($0.11)||$5.40 million||$5.30 million||View||N/A|
|5/14/2013||Q1 2013||($0.04)||($0.03)||$4.92 million||$5.60 million||View||N/A|
|11/13/2012||Q312||($0.07)||($0.05)||$4.50 million||$5.40 million||View||N/A|
Response Genetics (OTCMKTS:RGDXQ) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Response Genetics (OTCMKTS RGDXQ) News Headlines
Response Genetics (OTCMKTS:RGDXQ) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Response Genetics (OTCMKTS RGDXQ) Stock Chart for Tuesday, April, 24, 2018